Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) saw strong trading volume on Friday . 7,293,182 shares changed hands during mid-day trading, an increase of 1,280% from the previous session’s volume of 528,326 shares.The stock last traded at $1.53 and had previously closed at $1.53.

Separately, Zacks Investment Research raised shares of Ekso Bionics Holdings from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a research report on Friday, September 15th.

The company has a debt-to-equity ratio of 0.18, a current ratio of 6.09 and a quick ratio of 2.04.

Ekso Bionics Holdings (NASDAQ:EKSO) last issued its quarterly earnings results on Wednesday, November 8th. The company reported ($0.18) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.13) by ($0.05). The business had revenue of $1.60 million for the quarter, compared to analyst estimates of $2.40 million. Ekso Bionics Holdings had a negative return on equity of 323.00% and a negative net margin of 343.53%. sell-side analysts forecast that Ekso Bionics Holdings, Inc. will post -0.81 earnings per share for the current year.

In other news, insider Russ Angold sold 28,254 shares of the firm’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $1.53, for a total value of $43,228.62. Following the completion of the sale, the insider now owns 250,678 shares in the company, valued at approximately $383,537.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last 90 days, insiders bought 41,264 shares of company stock valued at $48,255 and sold 259,352 shares valued at $399,373. 7.10% of the stock is currently owned by company insiders.

Several hedge funds have recently added to or reduced their stakes in EKSO. Vanguard Group Inc. lifted its stake in shares of Ekso Bionics Holdings by 32.9% in the 2nd quarter. Vanguard Group Inc. now owns 711,082 shares of the company’s stock worth $1,650,000 after acquiring an additional 176,197 shares during the period. National Planning Corp lifted its stake in shares of Ekso Bionics Holdings by 116.2% in the 2nd quarter. National Planning Corp now owns 234,450 shares of the company’s stock worth $537,000 after acquiring an additional 126,000 shares during the period. Carl Domino Inc increased its holdings in shares of Ekso Bionics Holdings by 125.2% in the 3rd quarter. Carl Domino Inc now owns 184,788 shares of the company’s stock valued at $224,000 after purchasing an additional 102,734 shares in the last quarter. Finally, Intellectus Partners LLC increased its holdings in shares of Ekso Bionics Holdings by 5.3% in the 2nd quarter. Intellectus Partners LLC now owns 105,294 shares of the company’s stock valued at $244,000 after purchasing an additional 5,294 shares in the last quarter. Institutional investors own 2.62% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/ekso-bionics-holdings-inc-ekso-sees-unusually-high-trading-volume/1697970.html.

About Ekso Bionics Holdings

Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.